A Biofeedback Training in Schoolchildren With an Attention-Deficit/Hyperactivity Disorder (ADHD)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02572180 |
Recruitment Status : Unknown
Verified June 2016 by Dr. Ann-Christine Ehlis, University Hospital Tuebingen.
Recruitment status was: Recruiting
First Posted : October 8, 2015
Last Update Posted : June 24, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Attention-deficit Hyperactivity Disorder of Childhood or Adolescence Nos | Behavioral: EMG-based biofeedback training Behavioral: NIRS-based neurofeedback training | Not Applicable |

Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 90 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | A Biofeedback Training in Schoolchildren With an Attention-Deficit/Hyperactivity Disorder (ADHD): Differential Effects of Training in a 2D or 3D Environment |
Study Start Date : | September 2015 |
Estimated Primary Completion Date : | September 2017 |

Arm | Intervention/treatment |
---|---|
Active Comparator: NIRS-based NF in 3D
A near-infrared spectroscopy (NIRS)-based neurofeedback training in which participants learn to increase the BOLD signal in prefrontal cortical regions will take place in a 3D virtual reality classroom environment.
|
Behavioral: NIRS-based neurofeedback training |
Active Comparator: NIRS-based NF in 2D
A near-infrared spectroscopy (NIRS)-based neurofeedback training in which participants learn to increase the BOLD signal in prefrontal cortical regions will take place in a 2D (normal computer screen) classroom environment.
|
Behavioral: NIRS-based neurofeedback training |
Active Comparator: EMG-based BF in 3D
An electromyogram (EMG)-based biofeedback training in which participants learn to self-regulate activity of the musculi supraspinatus will take place in a 3D virtual reality classroom environment.
|
Behavioral: EMG-based biofeedback training |
- ADHD symptomatology [ Time Frame: 9 months ]ADHD symptomatology will be measured as evaluated by teachers and parents using the German long version of the Conners-3. Furthermore, data from accelerometer measures will provide information about motor hyperactivity. The SDQ and the KINDL will assess the children's and family's quality of life which is directly associated with ADHD symptomatology.
- Activity in diverse cortical regions and parallel behavioral performance [ Time Frame: 9 months ]The investigators measure prefrontal cortical activity using near-infrared spectroscopy and electroencephalography (EEG) during the verbal fluency task, the Go/NoGo and the n-back task. Behavioral performance on these tasks will also be assessed.
- Executive functions [ Time Frame: 9 months ]Using a variety of neuropsychological tests, the investigators aim at testing executive functioning using a digit span task, a matrices span task, the corsi block tapping task, and the stop signal task. Furthermore, parents and teachers will evaluate executive functioning with the BRIEF.
- Academic performance [ Time Frame: 9 months ]Academic performance in math and German will be assessed using an age-appropriate version of the LVD-M 2-4 and the SLRT-II.
- Sustained attention [ Time Frame: 9 months ]Sustained attention will be measured using the Conner's continuous performance task (CPT).
- Self-control and academic self-efficacy [ Time Frame: 9 months ]
These variables are assessed using adapted versions of the following questionnaires:
- Brief version of the self-control scale (for parents and children)
- Questionnaire on academic self-efficacy
- Expectations of parents [ Time Frame: 9 months ]The expectations of parents on the bio- and neurofeedback interventions will be assessed using an adapted version of the FERT.
- Motivation for the intervention [ Time Frame: 3-4 months ]Motivation of the participants for the intervention will be assessed directly before every training session starts using a short self-assessment mainkin. Furthermore, an electrocardiogram (ECG) allows the investigators to measure the heart-rate variability which is hypothesized to be directly associated with motivation.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 6 Years to 10 Years (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Going to school Grade 1-4.
- Clinical diagnosis of ADHD combined, predominantly inattentive or predominantly hyperactive-impulsive type according to DSM-V.
- IQ > 70 as assessed with the CFT 1-R or CFT 20-R (Weiß & Osterland, 2013; Weiß & Weiß, 2006).
- No additional serious physical, neurological or mental disorder as specified below.
Exclusion Criteria:
- Not going to school or in other Grades than 1-4.
- No clinical diagnosis of ADHD according to the DSM-V.
- IQ < 70 as assessed with the CFT 1-R or CFT 20-R (Weiß & Osterland, 2013; Weiß & Weiß, 2006).
- Parent reported diagnosis of the following: Serious physical illness or chronic diseases such as lung disease, heart disease, diabetes, hypertension, and rheumatic diseases; Neurological disorders including stroke, multiple sclerosis and epilepsy; indicated psychiatric disorders including obsessive-compulsive disorder, chronic tics, Tourette syndrome, and suicidal behavior.
- Prior participation in a BF/NF training.
- Other psychotherapeutic treatment or any kind of attention training, also in the course of an ergotherapeutic treatment, while participating in the study.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02572180
Contact: Friederike Blume | +49707129 ext 75633 | friederike.blume@uni-tuebingen.de | |
Contact: Justin Hudak, M.Sc. | +49707129 ext 82315 | justin.hudak@lead.uni-tuebingen.de |
Germany | |
LEAD Graduate School | Recruiting |
Tuebingen, Baden-Wuerttemberg, Germany, 72074 | |
Contact: Friederike Blume +49707129 ext 75633 friederike.blume@uni-tuebingen.de | |
Contact: Justin Hudak, M.Sc. +49707129 ext 82315 justin.hudak@lead.uni-tuebingen.de |
Principal Investigator: | Ann-Christine Ehlis, Dr. | Psychiatry and Psychotherapy (Uni Tübingen) | |
Principal Investigator: | Caterina Gawrilow, Prof. | School Psychology (Uni Tübingen) | |
Principal Investigator: | Thomas Dresler, Dr. | LEAD Graduate School | |
Principal Investigator: | Tobias J Renner, Prof. | Child and Adolescence Psychiatry (Uni Tübingen) |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Dr. Ann-Christine Ehlis, Wissenschaftliche Leiterin der Arbeitsgruppe Psychophysiologie und Optische Bildgebung, University Hospital Tuebingen |
ClinicalTrials.gov Identifier: | NCT02572180 |
Other Study ID Numbers: |
LEAD_BluHud_524 |
First Posted: | October 8, 2015 Key Record Dates |
Last Update Posted: | June 24, 2016 |
Last Verified: | June 2016 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Hyperkinesis Attention Deficit Disorder with Hyperactivity Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders |
Mental Disorders Dyskinesias Neurologic Manifestations Nervous System Diseases |